Supportive Long Term Effects Protocols / Clinical Studies

Non-therapeutic protocols address such issues as side effects or long-term effects of therapy, quality of life, making testing easier on the children, prevention of pain, and issues related to nutrition and stress. There are also tissue and blood banking protocols for laboratory researchers who are studying diseases and searching for underlying causes and cures. The research at St. Jude is designed to include all aspects related to the care of sick children and their families.


Feasibility and Efficacy of Transcranial Direct Current Stimulation (tDCS) and Cognitive Training for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia

For: Childhood acute lymphoblastic leukemia


Protocol for Collecting Long-Term Follow-Up Data on Recipients of Hematopoietic Stem Cell Transplant


Brain Integrity in Survivors of Hodgkin Lymphoma Treated with Thoracic Radiation

For: Hodgkin lymphoma survivors


Resistance and Aerobic Exercise for Subclinical Anthracycline Cardiomyopathy

For: Survivors of childhood cancer


A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer

For: Childhood Cancer


Lactation Outcomes Among Survivors of Pediatric Cancer


Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors

For: Leukemia


Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Congestive Heart Failure (PREVENT-CHF):A Phase IIB Randomized Placebo-Controlled Trial

For: congestive heart failure


Establishment of a Lifetime Cohort of Adults Surviving Childhood Cancer


Protocol for Collecting Data on Childhood Cancer Survivors


Transfusional Iron Overload Among Leukemia Survivors

For: Iron overload in leukemia survivors


Feasibility Study of Neurocognitive Rehabilitation in Adult Survivors of Childhood Cancer


A Randomized Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer


Non St. Jude Protocols


Childhood Cancer Survivor Study

For: Childhood cancer incidence and survival


Low-dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction: A Phase IIB Randomized Placebo-Controlled Trial

For: For survivors of Hodgkin lymphoma